Aihua Yao

机构：Chinese Academy of Medical Sciences & Peking Union Medical College, Jiangsu Province Hospital, Southeast University, Nanjing Medical University · ORCID：0000-0003-3144-6243

发表论文 35 篇 · 总被引 1056 次 · h-index 16

代表论文

• Efficacy and safety of camrelizumab plus apatinib during the perioperative period in resectable hepatocellular carcinoma: a single-arm, open label, phase II clinical trial (2022 · Journal for ImmunoTherapy of Cancer · 被引 218)
• IL-22 is related to development of human colon cancer by activation of STAT3 (2013 · BMC Cancer · 被引 183)
• PNPLA3 polymorphisms (rs738409) and non‐alcoholic fatty liver disease risk and related phenotypes: a meta‐analysis (2015 · Journal of Gastroenterology and Hepatology · 被引 64)
• Circulating circRNA predicting the occurrence of hepatocellular carcinoma in patients with HBV infection (2020 · Journal of Cellular and Molecular Medicine · 被引 35)
• Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma (2016 · Stem Cells · 被引 35)
• Lithium exacerbates hepatic ischemia/reperfusion injury by inhibiting GSK-3β/NF-κB-mediated protective signaling in mice (2012 · European Journal of Pharmacology · 被引 32)